Equinix (EQIX) CEO sells 4,230 shares and gains major RSU grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Equinix Inc. CEO and President Adaire Fox-Martin reported a mix of stock sales and equity awards. On February 18, 2026, she completed open-market sales totaling 4,230 common shares at weighted-average prices ranging from about $925 to $944 per share under a Rule 10b5-1 trading plan to raise funds for required withholding taxes tied to vesting restricted stock units. Following these sales, she directly held 18,625.661 common shares. On February 17, 2026, she acquired equity through compensation: 10,594 performance-based restricted stock units were granted, and 2,669 and 5,297 restricted stock units were converted into the same number of common shares. A footnote also notes the acquisition of 32.243 shares through the employee stock purchase plan on February 13, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,230 shares ($3,946,973)
Net Sell
21 txns
Insider
Fox-Martin Adaire
Role
CEO and President
Sold
4,230 shs ($3.95M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 101 | $925.5764 | $93K |
| Sale | Common Stock | 806 | $926.7666 | $747K |
| Sale | Common Stock | 403 | $927.3414 | $374K |
| Sale | Common Stock | 506 | $928.6281 | $470K |
| Sale | Common Stock | 174 | $929.3094 | $162K |
| Sale | Common Stock | 280 | $930.431 | $261K |
| Sale | Common Stock | 200 | $932.083 | $186K |
| Sale | Common Stock | 120 | $933.7598 | $112K |
| Sale | Common Stock | 120 | $934.3334 | $112K |
| Sale | Common Stock | 114 | $936.9416 | $107K |
| Sale | Common Stock | 86 | $938.6712 | $81K |
| Sale | Common Stock | 410 | $939.3293 | $385K |
| Sale | Common Stock | 150 | $940.1828 | $141K |
| Sale | Common Stock | 320 | $941.6838 | $301K |
| Sale | Common Stock | 200 | $942.774 | $189K |
| Sale | Common Stock | 240 | $943.835 | $227K |
| Exercise | Restricted Stock Units | 2,669 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 10,594 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 5,297 | $0.00 | -- |
| Exercise | Common Stock | 2,669 | $0.00 | -- |
| Exercise | Common Stock | 5,297 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 22,754.661 shares (Direct);
Restricted Stock Units — 2,668 shares (Direct);
Restricted Stock Unit — 10,594 shares (Direct)
Footnotes (1)
- 32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026. Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.00 to $925.95, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 18 to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.01 to $927.00 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.04 to $928.00 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.07 to $929.07 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.13 to $929.55 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.27 to $930.72 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.85 to $932.29 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.18 to $934.09 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.30 to $934.44 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $936.60 to $937.29 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.82 to $938.75 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.90 to $939.90 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $940.00 to $940.51 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.53 to $942.41 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.60 to $942.89 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $943.71 to $943.86 inclusive. On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service. Restricted stock unit award expires upon reporting person's termination of service. On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service.
FAQ
What did Equinix (EQIX) CEO Adaire Fox-Martin report in this Form 4?
Adaire Fox-Martin reported selling 4,230 Equinix common shares and receiving new restricted stock unit awards. The filing also shows RSU conversions into common stock and a small share purchase through the employee stock purchase plan.
What new restricted stock units did the Equinix (EQIX) CEO receive?
On February 17, 2026, the CEO received a grant of 10,594 performance-based restricted stock units. The filing also shows RSU conversions of 2,669 and 5,297 units into an equal number of common shares at no cash exercise price.
What performance conditions apply to the Equinix (EQIX) RSU awards?
Footnotes describe RSUs granted with performance conditions tied to AFFO, revenue, and EBITDA targets for specific years. Once the compensation committee certifies results, vesting occurs over several years, subject to the executive’s continued service with Equinix.